Cellastar Co., Ltd. has officially obtained the cell processing permit (Facility No.: FA3240005) from the Ministry of Health, Labour and Welfare (MHLW) as of December 2024 for its Cell Processing Facility (CPF).

This authorization certifies that our manufacturing and quality control systems for cell processing comply with the Act on the Safety of Regenerative Medicine and the Good Gene, Cellular, and Tissue-based Products Manufacturing Practice (GCTP) standards, establishing our status as a legally recognized stem cell processing operator under Japanese law.

We remain committed to advancing regenerative medicine by providing safe, high-quality cell products in close collaboration with medical institutions.